Cote d'Ivoire vs Sri Lanka: Access to anti-retroviral drugs, male
Cote d'Ivoire
69.0%
in 2024
Sri Lanka
71.0%
in 2024
Cote d'Ivoire rank
72nd
Sri Lanka rank
69th
Access to anti-retroviral drugs, male over time
- Cote d'Ivoire
- Sri Lanka
How they compare
Sri Lanka currently reports 71.0% against 69.0% in Cote d'Ivoire, a difference of 2.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Sri Lanka ahead.
Cote d'Ivoire ranks 72nd and Sri Lanka ranks 69th of 141 countries.
Cote d'Ivoire has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cote d'Ivoire | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.4% | 1.2% | 2.2% | Cote d'Ivoire |
| 2010s | 28.6% | 19.6% | 9.0% | Cote d'Ivoire |
| 2020s | 61.2% | 56.0% | 5.2% | Cote d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Cote d'Ivoire or Sri Lanka?
- Sri Lanka, at 71.0% against 69.0% in Cote d'Ivoire as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Cote d'Ivoire and Sri Lanka?
- 2.0%, with Sri Lanka ahead.
- How many years of comparable data are there for Cote d'Ivoire and Sri Lanka?
- 25 years are reported by both, from 2000 to 2024.
- How do Cote d'Ivoire and Sri Lanka rank globally for access to anti-retroviral drugs, male?
- Cote d'Ivoire ranks 72nd and Sri Lanka ranks 69th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.